Sentences with phrase «pharma dealmaking»

But the serial acquirers that defined the last decade of specialty pharma dealmaking — Teva Pharmaceuticals, Valeant Pharmaceuticals, and Endo International — are no longer in the position to take on bigger deals, as they're all saddled with too much debt.

Specialty pharma dealmaking fell off abruptly in 2017 with just $ 7 billion in deals, the lowest since 2009 according to consulting firm EY.

A tie - up between Takeda and Shire could signal a new era for specialty pharma dealmaking, say analysts and investors, as interest in the sector intensifies again.

Pharma dealmaking is starting to heat up — here's who likely to get acquired.

Not exact matches

The specialty pharma industry has historically been an area filled with dealmaking but has been more subdued over the past few years.